Thrive Capital now has 92% of its public stock portfolio in SpaceX

What's the deal? Thrive Capital, the New York venture firm founded by Josh KushnerDealroom has a profile for this one. Try Dealroom →, now has 92% of its publicly reported US stock portfolio in SpaceX. Its third-quarter 13F filing shows the SpaceX position worth about $7.1B at the end of September, out of roughly $7.6B in total, after Thrive added 27.9 million shares in the quarter, a 148% increase on Q2, according to Benzinga, citing 13F data.

The rest of the book: Only six holdings are listed: SpaceX, Amazon ($225M), Shopify ($133M), Oscar Health notes ($132M), Figma ($92M) and a new $25M stake in Securitize. Thrive also sold 6.3 million Oscar Health shares in the quarter. SpaceX shares traded between $104.83 and $171.74 during Q3 and closed the quarter at $150.86, so it is not clear what Thrive paid for the extra stock.

Context: Thrive was an early private investor in SpaceX, and the bet has become one of the most concentrated public positions held by a major venture firm. A 13F only covers US-listed equities, so it leaves out the bulk of Thrive's private venture portfolio.

Sources: Benzinga
@rdominguezibar on X